P. N. Roset

1.5k total citations
22 papers, 1.1k citations indexed

About

P. N. Roset is a scholar working on Toxicology, Pharmacology and Clinical Psychology. According to data from OpenAlex, P. N. Roset has authored 22 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Toxicology, 11 papers in Pharmacology and 9 papers in Clinical Psychology. Recurrent topics in P. N. Roset's work include Forensic Toxicology and Drug Analysis (11 papers), Psychedelics and Drug Studies (9 papers) and Cannabis and Cannabinoid Research (8 papers). P. N. Roset is often cited by papers focused on Forensic Toxicology and Drug Analysis (11 papers), Psychedelics and Drug Studies (9 papers) and Cannabis and Cannabinoid Research (8 papers). P. N. Roset collaborates with scholars based in Spain, Italy and Switzerland. P. N. Roset's co-authors include Magı́ Farré, Rafael de la Torre, Jordi Camı́, Jordi Ortuño, Jordi Segura, Manuel Mas, Rudolf Brenneisen, E. Menoyo, Mitona Pujadas and Nieves Pizarro and has published in prestigious journals such as Annals of the New York Academy of Sciences, Journal of Pharmacology and Experimental Therapeutics and Life Sciences.

In The Last Decade

P. N. Roset

22 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. N. Roset Spain 15 708 571 449 379 96 22 1.1k
Marilyn A. Huestis United States 21 592 0.8× 132 0.2× 918 2.0× 286 0.8× 73 0.8× 32 1.4k
Jacques D. Nguyen United States 14 229 0.3× 103 0.2× 457 1.0× 455 1.2× 43 0.4× 28 789
S. Hill United Kingdom 17 652 0.9× 426 0.7× 490 1.1× 325 0.9× 114 1.2× 40 1.4k
Claudia Rimondo Italy 14 373 0.5× 228 0.4× 328 0.7× 389 1.0× 137 1.4× 25 855
Jo Ellen Dyer United States 14 790 1.1× 236 0.4× 195 0.4× 404 1.1× 80 0.8× 21 1.1k
Cristina Sempio United States 17 314 0.4× 87 0.2× 588 1.3× 143 0.4× 108 1.1× 56 869
Erin L Karschner United States 19 609 0.9× 104 0.2× 1.1k 2.4× 226 0.6× 95 1.0× 31 1.4k
S. Davies United Kingdom 12 864 1.2× 610 1.1× 220 0.5× 396 1.0× 101 1.1× 17 1.0k
Anne‐Laure Pélissier‐Alicot France 16 289 0.4× 122 0.2× 290 0.6× 129 0.3× 21 0.2× 68 836
Sandra Poudevida Spain 9 243 0.3× 207 0.4× 208 0.5× 198 0.5× 22 0.2× 9 436

Countries citing papers authored by P. N. Roset

Since Specialization
Citations

This map shows the geographic impact of P. N. Roset's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. N. Roset with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. N. Roset more than expected).

Fields of papers citing papers by P. N. Roset

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. N. Roset. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. N. Roset. The network helps show where P. N. Roset may publish in the future.

Co-authorship network of co-authors of P. N. Roset

This figure shows the co-authorship network connecting the top 25 collaborators of P. N. Roset. A scholar is included among the top collaborators of P. N. Roset based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. N. Roset. P. N. Roset is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miranda‐Rius, Jaume, Lluís Brunet‐Llobet, P. N. Roset, Magı́ Farré, & Carlos Alberto Mendieta Pino. (2012). Reliability of two measurement indices for gingival enlargement. Journal of Periodontal Research. 47(6). 776–782. 19 indexed citations
2.
Peiró, Ana M., Magı́ Farré, P. N. Roset, et al.. (2012). Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 2 h apart. Psychopharmacology. 225(4). 883–893. 36 indexed citations
3.
Farré, Magí, et al.. (2008). Study of paracetamol 1g oral solution bioavailability. Methods and Findings in Experimental and Clinical Pharmacology. 30(1). 37–37. 8 indexed citations
4.
Farré, Magı́, et al.. (2005). Estudio de la biodisponibilidad en magnitud y en velocidad de comprimidos de ibuprofeno. Reumatología Clínica. 1(3). 155–160. 1 indexed citations
5.
Farré, Magı́, Rafael de la Torre, P. N. Roset, et al.. (2004). Repeated doses administration of MDMA in humans: pharmacological effects and pharmacokinetics. Psychopharmacology. 173(3-4). 364–375. 105 indexed citations
6.
Pacifici, Roberta, P. Zuccaro, Magı́ Farré, et al.. (2002). Cell‐Mediated Immune Response in MDMA Users After Repeated Dose Administration. Annals of the New York Academy of Sciences. 965(1). 421–433. 37 indexed citations
7.
Pizarro, Nieves, Jordi Ortuño, Mercè Farré, et al.. (2002). Determination of MDMA and its Metabolites in Blood and Urine by Gas Chromatography-Mass Spectrometry and Analysis of Enantiomers by Capillary Electrophoresis. Journal of Analytical Toxicology. 26(3). 157–165. 94 indexed citations
8.
Brunet‐Llobet, Lluís, Jaume Miranda‐Rius, P. N. Roset, et al.. (2001). Prevalence and risk of gingival enlargement in patients treated with anticonvulsant drugs. European Journal of Clinical Investigation. 31(9). 781–788. 33 indexed citations
9.
Pacifici, Roberta, Magı́ Farré, Simona Pichini, et al.. (2001). Sweat Testing of MDMA with the Drugwipe(R) Analytical Device: A Controlled Study with Two Volunteers. Journal of Analytical Toxicology. 25(2). 144–146. 28 indexed citations
10.
Pacifici, Roberta, P. Zuccaro, Simona Pichini, et al.. (2001). Acute Effects of 3,4-Methylenedioxymethamphetamine Alone and in Combination with Ethanol on the Immune System in Humans. Journal of Pharmacology and Experimental Therapeutics. 296(1). 207–215. 63 indexed citations
11.
Pacifici, Roberta, P. Zuccaro, Magı́ Farré, et al.. (2000). Immunomodulating Activity of MDMA. Annals of the New York Academy of Sciences. 914(1). 215–224. 29 indexed citations
12.
Torre, Rafael de la, Magı́ Farré, P. N. Roset, et al.. (2000). Pharmacology of MDMA in Humans. Annals of the New York Academy of Sciences. 914(1). 225–237. 123 indexed citations
13.
Torre, Rafael de la, Magı́ Farré, Jordi Ortuño, et al.. (2000). Non‐linear pharmacokinetics of MDMA (‘ecstasy’) in humans. British Journal of Clinical Pharmacology. 49(2). 104–109. 267 indexed citations
14.
Pacifici, Roberta, P. Zuccaro, M. Farré, et al.. (2000). [Immunomodulator properties of ecstasy (MDMA)].. PubMed. 36(1). 69–75. 4 indexed citations
15.
Pacifici, Roberta, P. Zuccaro, Magı́ Farré, et al.. (1999). Immunomodulating properties of MDMA alone and in combination with alcohol: A pilot study. Life Sciences. 65(26). PL309–PL316. 33 indexed citations
16.
17.
Farré, Magı́, et al.. (1997). Cocaine and Alcohol Interactions in Humans: Neuroendocrine Effects and Cocaethylene Metabolism. Journal of Pharmacology and Experimental Therapeutics. 283(1). 164–176. 102 indexed citations
18.
Ortuño, Jordi, M. Farré, P. N. Roset, et al.. (1997). 152 PHARMACOKINETICS OF ECSTASY (MDMA) IN HEALTHY SUBJECTS. Therapeutic Drug Monitoring. 19(5). 585–585. 6 indexed citations
19.
Herrero, Enrique, et al.. (1992). Therapeutic efficacy and safety of the new antimycotic sertaconazole in the treatment of cutaneous dermatophytosis.. PubMed. 42(5A). 760–3. 12 indexed citations
20.
Umbert, Pablo, et al.. (1992). Therapeutic efficacy and safety of the new antimycotic sertaconazole in the treatment of Pityriasis versicolor.. PubMed. 42(5A). 764–7. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marilyn A. Huestis Breakdown of academic impact, for papers by Jacques D. Nguyen Breakdown of academic impact, for papers by S. Hill Breakdown of academic impact, for papers by Claudia Rimondo Breakdown of academic impact, for papers by Jo Ellen Dyer Breakdown of academic impact, for papers by Cristina Sempio Breakdown of academic impact, for papers by Erin L Karschner Breakdown of academic impact, for papers by S. Davies Breakdown of academic impact, for papers by Anne‐Laure Pélissier‐Alicot Breakdown of academic impact, for papers by Sandra Poudevida
Rankless by CCL
2026